SCHEMBL9157680

SCHEMBL9157680

c1cncc([C]2CNCCO2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.45
CYP3A4 P08684 3/20 0.45
ALDH1A1 P00352 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP11B2 P19099 2/20 0.44
CYP11B1 P15538 1/20 0.44
NISCH Q9Y2I1 1/20 0.44
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.40
BTK Q06187 1/20 0.39
CYP2E1 P05181 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1171191 0.78 PRCP (0.37) CYP3A4ALDH1A1SMN1; SMN2NPC1RAB9A
SCHEMBL10200402 0.74 CYP2A6 (0.39) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
Hydrochloric Acid SCHEMBL3276504 0.74 SSTR4 (0.43) CYP11B2CYP11B1
SCHEMBL5171999 0.74 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL8352424 0.70 CYP2A6 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL28115303 0.69 PDE3B (0.33)
SCHEMBL4790022 0.68 HTR2A (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL38661030 0.68 ALDH1A1 (0.57) CYP2A6CYP3A4ALDH1A1CYP1A2NISCH
SCHEMBL30269982 0.68 HTR2A (0.49) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2
SCHEMBL2722566 0.67 ALDH1A1 (0.50) CYP2A6CYP3A4ALDH1A1CYP1A2CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5459142-A Autoimmune disease, atherosclerosis, antiischemic agents and nephritis OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-10-17 US disclosed
EP-0511879-B1 Pyrazine derivatives OTSUKA PHARMA CO LTD (JP) 1995-03-22 EP disclosed
EP-0511879-A1 Pyrazine derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-04 EP disclosed